MORGAN STANLEY - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 32 filers reported holding NRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$12,304
-46.2%
47,3260.0%0.00%
Q2 2023$22,882
-26.6%
47,3260.0%0.00%
Q1 2023$31,193
-44.2%
47,326
-6.0%
0.00%
Q4 2022$55,875
+29.9%
50,338
-15.1%
0.00%
Q3 2022$43,000
+30.3%
59,313
+5.2%
0.00%
Q2 2022$33,000
-74.2%
56,365
+8.8%
0.00%
Q1 2022$128,000
-53.3%
51,797
-9.7%
0.00%
Q4 2021$274,000
-28.1%
57,344
+39.7%
0.00%
Q3 2021$381,000
-17.7%
41,052
+3.0%
0.00%
Q2 2021$463,00039,8690.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 325,000$84,5000.06%
Texas Capital Bank Wealth Management Services Inc 63,290$16,4550.00%
XTX Topco Ltd 11,809$3,0700.00%
United Asset Strategies, Inc. 18,300$4,7580.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 160,700$41,7820.00%
UBS Group AG 1,210$3150.00%
NewEdge Advisors, LLC 7,125$1,8530.00%
Lido Advisors, LLC 13,000$3,3800.00%
OSAIC HOLDINGS, INC. 11,125$2,8910.00%
WELLS FARGO & COMPANY/MN 5,379$1,3990.00%
View complete list of NRX PHARMACEUTICALS INC shareholders